Charts Northwest Biotherapeutics, Inc.

Stocks

Market Closed - OTC Markets Other stock markets 20:59:27 24/07/2026 BST			5-day change	1st Jan Change
0.1717 ^USD	+1.53%		+1.78%	-24.96%

07-08	Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of Dcvax-L for Glioblastoma	CI
05-15	Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

ProRealTime Chart